To investigate the clinical significance of PRG4 in HCC, patients with HCC were divided into low expression (n=65) and high expression (n=52) groups according to a cutoff value (3396.83 ng/mL, AUC=0.823, 95% CI=0.744-0.902). Here, PRG4 is linked to hepatocellular carcinoma.